Microbiome
This function is exclusive for Premium subscribers
-
DATABASE (14)
-
ARTICLES (14)
NovoNutients uses CO2 and other emissions to produce cost-effective and environmentally-friendly protein-rich fish feed, a circular solution to aquaculture's fishmeal supply problem.
NovoNutients uses CO2 and other emissions to produce cost-effective and environmentally-friendly protein-rich fish feed, a circular solution to aquaculture's fishmeal supply problem.
The biotech will expand its popular range of organic and probiotic treats for dogs and cats with cell-based pet food, planned for launch in 2022.
The biotech will expand its popular range of organic and probiotic treats for dogs and cats with cell-based pet food, planned for launch in 2022.
With a 55-tone capacity to produce fungi-based proteins annually, Mycorena’s Gothenburg facility will showcase its mycoprotein R&D and spur commercial expansion across Europe.
With a 55-tone capacity to produce fungi-based proteins annually, Mycorena’s Gothenburg facility will showcase its mycoprotein R&D and spur commercial expansion across Europe.
East Ventures-backed microbiome personalized skincare firm is also known for helping produce Indonesia's first Covid-19 test kit, as part of state R&D collaboration.
East Ventures-backed microbiome personalized skincare firm is also known for helping produce Indonesia's first Covid-19 test kit, as part of state R&D collaboration.
Having backed some of the most successful US tech companies such as Facebook, PayPal and SpaceX, Oakhouse Partners is a micro-VC headquartered in San Francisco. Led by Jason Portnoy, Andrew Maguire and Stephanie Fernandez, the firm mainly backs companies based in the Bay Area and within the US. Currently focused on breakthrough technologies like blockchain, robotics, 3D printing and CRISPR, Oakhouse Partners typically participates in seed rounds with investments of $250,000–500,000 and in Series A rounds of $1m–1.5m.
Having backed some of the most successful US tech companies such as Facebook, PayPal and SpaceX, Oakhouse Partners is a micro-VC headquartered in San Francisco. Led by Jason Portnoy, Andrew Maguire and Stephanie Fernandez, the firm mainly backs companies based in the Bay Area and within the US. Currently focused on breakthrough technologies like blockchain, robotics, 3D printing and CRISPR, Oakhouse Partners typically participates in seed rounds with investments of $250,000–500,000 and in Series A rounds of $1m–1.5m.
Bright Success Capital Ltd is a Hong Kong-based family office founded by Hilton Tam who has previously worked at Seagate Technology and Cisco Systems. He specializes in R&D, supply chain processes and consumer electronics manufacturing. Successful investments include Flixibus and N26. The VC manages a portfolio of companies involved in manufacturing and supply chains specifically for hardware components, medical devices, drones and consumer robotics. Its investment focus covers diverse sectors like robotics, fintech, healthcare, enterprise software and deep tech.
Bright Success Capital Ltd is a Hong Kong-based family office founded by Hilton Tam who has previously worked at Seagate Technology and Cisco Systems. He specializes in R&D, supply chain processes and consumer electronics manufacturing. Successful investments include Flixibus and N26. The VC manages a portfolio of companies involved in manufacturing and supply chains specifically for hardware components, medical devices, drones and consumer robotics. Its investment focus covers diverse sectors like robotics, fintech, healthcare, enterprise software and deep tech.
Founded in 1997, Seventure Partners is one of Europe’s most prolific VC investors with a portfolio of over 200 startups across both tech and non-tech sectors. The French VC has also managed more than 40 exits in total. It mainly focuses on fintech and insurtech, French and German startups and in life sciences in Europe, North America and Asia.Its five funds cover different market segments, ranging from €24m–€200m, with investments of €500,000–€10m per round. Total funding for a company can reach €20m, right through the early to late stages. Recent investments include the $6.7m Series A round of US biotech Dermala and the $10.7m Series A round of US self-cleaning water bottle startup LARQ.
Founded in 1997, Seventure Partners is one of Europe’s most prolific VC investors with a portfolio of over 200 startups across both tech and non-tech sectors. The French VC has also managed more than 40 exits in total. It mainly focuses on fintech and insurtech, French and German startups and in life sciences in Europe, North America and Asia.Its five funds cover different market segments, ranging from €24m–€200m, with investments of €500,000–€10m per round. Total funding for a company can reach €20m, right through the early to late stages. Recent investments include the $6.7m Series A round of US biotech Dermala and the $10.7m Series A round of US self-cleaning water bottle startup LARQ.
Mayfield Fund is one of Silicon Valley's oldest venture capital firms. Founded by Wally Davis and Thomas J Davis Jr in 1969, the VC is based in Menlo Park, California.Current investments include CRISPR-focused companies like Mammoth Biosciences and biotech startup iLoF,l which is focused on creating a digital library of optical fingerprints for non-invasive patient screening, early diagnostics and personalized medical treatments.. With a total of $2.5bn assets under management, the firm focuses mainly on early-stage to growth-stage investments. The VC has also backed startups like Marketo, Lyft and SolarCity. Most of Mayfield’s exits took place during the 2008 financial crisis and through subsequent funds.In April 2020, amid the Covid-19 pandemic, Mayfield announced two new funds which raised $750m in total. Mayfield XVI will invest in early-stage companies, while Mayfield Select II will focus on growth-stage companies outside its portfolio. The company said last year that it has raised a similar size fund every four years and has invested in 30 companies per fund. It primarily leads Series A investments.
Mayfield Fund is one of Silicon Valley's oldest venture capital firms. Founded by Wally Davis and Thomas J Davis Jr in 1969, the VC is based in Menlo Park, California.Current investments include CRISPR-focused companies like Mammoth Biosciences and biotech startup iLoF,l which is focused on creating a digital library of optical fingerprints for non-invasive patient screening, early diagnostics and personalized medical treatments.. With a total of $2.5bn assets under management, the firm focuses mainly on early-stage to growth-stage investments. The VC has also backed startups like Marketo, Lyft and SolarCity. Most of Mayfield’s exits took place during the 2008 financial crisis and through subsequent funds.In April 2020, amid the Covid-19 pandemic, Mayfield announced two new funds which raised $750m in total. Mayfield XVI will invest in early-stage companies, while Mayfield Select II will focus on growth-stage companies outside its portfolio. The company said last year that it has raised a similar size fund every four years and has invested in 30 companies per fund. It primarily leads Series A investments.
Beyond Investing is a Geneva-based firm investing in early-stage venture capital and equity growth startups mainly in European developed markets. With average investments of €200,000, the firm’s core investment strategy focuses on sustainability with an investment period lasting 5–10 years.The impact investor targets innovative startups involved in vegan, cruelty-free and plant-based alternatives; biotechnologies, foodtech, new materials, clothing and lifestyle sectors. Successful portfolio foodtechs include Mosa Meat, BlueNalu and Shiok Meats.With a team of vegan finance professionals in the US and Europe, Beyond Investing listed the first US Vegan Climate ETF (VEGN) on the New York Stock Exchange in September 2019. The ETF tracks Beyond Investing’s US Vegan Climate Index which covers an index of 495 of the largest-capitalization companies in the US stock market. The ethical investment option aims to exclude stocks in companies with activities that are not aligned with its vegan-themed, cruelty-free and fossil-fuel-free investing ethos.
Beyond Investing is a Geneva-based firm investing in early-stage venture capital and equity growth startups mainly in European developed markets. With average investments of €200,000, the firm’s core investment strategy focuses on sustainability with an investment period lasting 5–10 years.The impact investor targets innovative startups involved in vegan, cruelty-free and plant-based alternatives; biotechnologies, foodtech, new materials, clothing and lifestyle sectors. Successful portfolio foodtechs include Mosa Meat, BlueNalu and Shiok Meats.With a team of vegan finance professionals in the US and Europe, Beyond Investing listed the first US Vegan Climate ETF (VEGN) on the New York Stock Exchange in September 2019. The ETF tracks Beyond Investing’s US Vegan Climate Index which covers an index of 495 of the largest-capitalization companies in the US stock market. The ethical investment option aims to exclude stocks in companies with activities that are not aligned with its vegan-themed, cruelty-free and fossil-fuel-free investing ethos.
Since 2005, Demeter Partners has been one of the major VC and private equity funds supporting technology companies in developing solutions for ecological and energy transitions. The firm typically invests €1m–€30m in early and growth stages of startups. With assets worth over €1bn under management, its portfolio in 2019 was estimated to have cut 4.3m tons of CO2 with 575 GWh of clean energy produced. In 2021, Demeter was named the “Best Sustainable Equity investor” by a panel of former Fortune 500 individuals, global experts and industry leaders to recognize Demeter’s commitment to the UN’s SDG and ESG strategy.
Since 2005, Demeter Partners has been one of the major VC and private equity funds supporting technology companies in developing solutions for ecological and energy transitions. The firm typically invests €1m–€30m in early and growth stages of startups. With assets worth over €1bn under management, its portfolio in 2019 was estimated to have cut 4.3m tons of CO2 with 575 GWh of clean energy produced. In 2021, Demeter was named the “Best Sustainable Equity investor” by a panel of former Fortune 500 individuals, global experts and industry leaders to recognize Demeter’s commitment to the UN’s SDG and ESG strategy.
The Plantbase Foundation is a non-profit institution run by entrepreneur and impact investor Willem Blom based in The Netherlands. Most of the Plantbase activities are backed by donors. At least 80% of the donations are used to support enterprises that facilitate the shift from animal agriculture to a vegan lifestyle. The foundation has invested in foodtechs involved in the meat, fish and dairy industries; as well as food delivery and apps. Its portfolio includes fast-growing startups like Heura, Meatable, Livekindly and Mission Barns. It also works with investment partners like Kale United, Mile High Vegan Network, Vegan Entrepreneurs Network and GlassWall Syndicate.
The Plantbase Foundation is a non-profit institution run by entrepreneur and impact investor Willem Blom based in The Netherlands. Most of the Plantbase activities are backed by donors. At least 80% of the donations are used to support enterprises that facilitate the shift from animal agriculture to a vegan lifestyle. The foundation has invested in foodtechs involved in the meat, fish and dairy industries; as well as food delivery and apps. Its portfolio includes fast-growing startups like Heura, Meatable, Livekindly and Mission Barns. It also works with investment partners like Kale United, Mile High Vegan Network, Vegan Entrepreneurs Network and GlassWall Syndicate.
Future Positive Capital is a Paris-based VC with a second office in London. Its investments cover deep-technology companies applying AI, biotechnology, synthetic biology, as well as robotics. Co-funded in 2016 by ex-Index Ventures associate Sofia Hmich along with Alexandre Terrien and Michael Rosen; it has made 18 investments to date. In 2019 Future Positive raised over $57m pan-European impact investment fund, claiming that most European VCs are continuing to staying focused on sectors, such as consumer, fintech, and marketing, or web and mobile technologies. Future Positive’s belief is that there is instead, a long-tail of investment opportunities to back businesses that actually tackle “the world’s most pressing problems”.Through this fund, it will back throughout Seed and Series A stages, with the possibility to follow up on Series B investing between around €300,000 and €5m. Since then the company has backed startups in the like of BioBeats, an AI company focused on preventative mental health, cell-based startup Meatable, and more recently NotCo, the Chilean unicorn disrupting the food and beverage sector with AI-enabled plant-based products.The team counts on an extensive network of mentors, innovators, impact angel investors and entrepreneurs such as F1 pilots Nico Rosberg, the MD of Alibaba France Sebastien Badault, the Omid Ashtari the President of Citymapper amongst others.
Future Positive Capital is a Paris-based VC with a second office in London. Its investments cover deep-technology companies applying AI, biotechnology, synthetic biology, as well as robotics. Co-funded in 2016 by ex-Index Ventures associate Sofia Hmich along with Alexandre Terrien and Michael Rosen; it has made 18 investments to date. In 2019 Future Positive raised over $57m pan-European impact investment fund, claiming that most European VCs are continuing to staying focused on sectors, such as consumer, fintech, and marketing, or web and mobile technologies. Future Positive’s belief is that there is instead, a long-tail of investment opportunities to back businesses that actually tackle “the world’s most pressing problems”.Through this fund, it will back throughout Seed and Series A stages, with the possibility to follow up on Series B investing between around €300,000 and €5m. Since then the company has backed startups in the like of BioBeats, an AI company focused on preventative mental health, cell-based startup Meatable, and more recently NotCo, the Chilean unicorn disrupting the food and beverage sector with AI-enabled plant-based products.The team counts on an extensive network of mentors, innovators, impact angel investors and entrepreneurs such as F1 pilots Nico Rosberg, the MD of Alibaba France Sebastien Badault, the Omid Ashtari the President of Citymapper amongst others.
Cambridge Enterprise Venture Partners
A Cambridge-based investor, founded in 2006, that exists to support spin-off companies created at the city’s university with an emphasis on social impact. It currently has 57 companies in its portfolio, almost entirely in the areas of life and physical sciences, which have, in total, raised over £2bn in further investment and grant funding.Its most recent investments include in the June 2021 £3m seed round of Gallium Nitride semiconductor engineering company Porotech and in the January 2021 $20m Series A round of quantum computing innovators Riverlane.
A Cambridge-based investor, founded in 2006, that exists to support spin-off companies created at the city’s university with an emphasis on social impact. It currently has 57 companies in its portfolio, almost entirely in the areas of life and physical sciences, which have, in total, raised over £2bn in further investment and grant funding.Its most recent investments include in the June 2021 £3m seed round of Gallium Nitride semiconductor engineering company Porotech and in the January 2021 $20m Series A round of quantum computing innovators Riverlane.
Founded in 2012 in San Francisco, Joyance invests in the “vectors of happiness” that it classifies as areas of science, including genetics and bioscience, the microbiome, neuroscience, virtual and augmented reality, and foodtech. It also invests in the area of social networking. Its investments are made through its management company, Ataraxia, and many have a European focus. It currently has 115 companies in its portfolio, with recent investments including in the August 2021 $3.6m seed round of Polish bionic limb manufacturer and in the July 2021 $8m Series A round of Israeli sports injury AI platform Zone7.
Founded in 2012 in San Francisco, Joyance invests in the “vectors of happiness” that it classifies as areas of science, including genetics and bioscience, the microbiome, neuroscience, virtual and augmented reality, and foodtech. It also invests in the area of social networking. Its investments are made through its management company, Ataraxia, and many have a European focus. It currently has 115 companies in its portfolio, with recent investments including in the August 2021 $3.6m seed round of Polish bionic limb manufacturer and in the July 2021 $8m Series A round of Israeli sports injury AI platform Zone7.
Yali Bio: Recreating a juicy steak in plant-based alternatives
Founded by the former head of Impossible Foods’ pilot plant, this Bay Area genomics and foodtech startup is one of the first to engineer a better fat for plant-based meat
Smart Agrifood Summit 2021: A global innovation ecosystem is needed to catch up with other sectors
Investors from SVG Ventures/THRIVE, Pinduoduo and others agree that players must join forces to boost agrifood tech investment, internationally and across the value chain
Forward Fooding: Ranking the world's agrifood startups on success and sustainability
The collaborative platform has opened applications for its FoodTech500 global ranking of agrifood startups; counts over 7,000 startups and scaleups mapped so far
NovoNutrients: Tackling the dual problems of CO2 emissions and over-fishing
The first to transform CO2 to fish food, NovoNutrients is trialing with industry giants Skretting and Chevron, and will soon raise Series A funding
Because Animals: Pioneering cultured meat for pets
The biotech startup is disrupting the pet food processing industry with cell-based food to minimize environmental “pawprints” and promote animal welfare
Sophie's Bionutrients: Alternative protein from microalgae
Inspired by fish in the ocean, the startup developed microalgae-based flour that can take on unlimited forms, textures or colors to make almost any alt protein product
Oscillum: The intelligent label to reduce food waste
The Spanish biotech startup has developed sensors embedded in biodegradable plastic labels to monitor “product freshness” beyond expiration dates, helping consumers to avoid food waste and save money
New Food Invest: Challenges of growing an alt-protein startup
Founders of three alt-protein startups in the US share what motivated them to start, their personal experiences growing the businesses, getting funding and finding strategic partners
New Food Invest: Opportunities in the European alt-protein space
With a record €2.4bn investment in 2019, Europe’s foodtech sector appears poised for continued growth, but startups, corporations, governments and even universities can do more, experts say
Bluepha to boost PHA bioplastics production with $30m fresh funding
The Beijing-based startup aims to produce 10,000 tons of PHA bioplastic a year and build a SynBio community through its STEM education spinoff, Bluepha Lab
Inspired by kangaroos, ProAgni wants to wean the livestock farming industry off antibiotics
Australia’s ProAgni is making grain-feed supplements to improve livestock growth, negate antibiotic use and even reduce methane emissions, all based on kangaroo gut health research
Big Idea Ventures Founder Andrew D Ive: Asia will lead cell-based meat innovation
In a wide-ranging interview, the managing general partner of the US- and Singapore-based foodtech investor also expounds on his goal to extend sustainability to the rest of the food sector, combining good returns with doing good
Xing Nong Fu: Using earthworms to create sustainable local farming and livelihoods
Worm castings can rehabilitate infertile land due to excessive soil salinity in just seven days, compared with three to five years using traditional methods, and 90% more cheaply
East Ventures raises funds, teams up with state agency to produce Covid-19 tests for Indonesia
East Ventures investee Nusantics has been working with state researchers to produce the prototype; expects mass production of the test kits soon
Search instead for portugal, b2b, hospitality
